(19)
(11) EP 1 212 326 A1

(12)

(43) Date of publication:
12.06.2002 Bulletin 2002/24

(21) Application number: 00959267.6

(22) Date of filing: 17.08.2000
(51) International Patent Classification (IPC)7: C07D 487/04, A61K 31/34, A61K 31/381, A61K 31/519
(86) International application number:
PCT/US0022/674
(87) International publication number:
WO 0127/114 (19.04.2001 Gazette 2001/16)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 27.08.1999 US 151233 P

(71) Applicant: ICN Pharmaceuticals, Inc.
Costa Mesa, CA 92626 (US)

(72) Inventors:
  • WANG, Guangyi
    Costa Mesa, CA 92626 (US)
  • TAM, Robert
    Costa Mesa, CA 92626 (US)
  • PIETRZKOWSKI, Zbigniew
    Costa Mesa, CA 92626 (US)

(74) Representative: Viering, Jentschura & Partner 
Postfach 22 14 43
80504 München
80504 München (DE)

   


(54) PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS